KONINKLIJKE PHILIPS N.V. (PHG) is a publicly traded Healthcare sector company. As of July 8, 2026, PHG trades at $27.55 with a market cap of $27.37B and a P/E ratio of 0.00. PHG moved -2.73% today. Year to date, PHG is +6.89%; over the trailing twelve months it is +22.81%. Its 52-week range spans $19.87 to $32.24. Rallies surfaces PHG's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Philips Launches Alturion Ultrasound System with FDA Clearance and AI-Powered Workflow: Philips received FDA 510(k) clearance and CE mark for its Alturion ultrasound system, launching in the US and Europe with a 24-inch monitor, responsive processing and AI-powered Elevate Plus measurements. The platform’s workflows automate measurements and share transducers with EPIQ Elite and Affiniti systems to streamline high-volume clinical exams.
| Metric | Value |
|---|---|
| Price | $27.55 |
| Market Cap | $27.37B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.99% |
| 52-Week High | $32.24 |
| 52-Week Low | $19.87 |
| Volume | 431.42K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
PHG analyst coverage data. Average price target: $0.00.